Brian C Cho1, Vincent M DeMario1, Michael C Grant1, Nadia B Hensley1, Charles H Brown1, Sachidanand Hebbar1, Kaushik Mandal2, Glenn J Whitman2, Steven M Frank3. 1. From the Department of Anesthesiology/Critical Care Medicine. 2. Department of Cardiac Surgery, The Johns Hopkins Medical Institutions, Baltimore, Maryland. 3. Department of Anesthesiology/Critical Care Medicine, Johns Hopkins Health System Blood Management Program, Faculty, Armstrong Institute for Patient Safety and Quality, The Johns Hopkins Medical Institutions, Baltimore, Maryland.
Abstract
BACKGROUND: Restrictive transfusion strategies supported by large randomized trials are resulting in decreased blood utilization in cardiac surgery. What remains to be determined, however, is the impact of lower discharge hemoglobin (Hb) levels on readmission rates. We assessed patients with higher versus lower Hb levels on discharge to compare 30-day readmission rates after coronary artery bypass grafting (CABG). METHODS: We retrospectively evaluated 1552 patients undergoing isolated CABG at our institution from January 2013 to May 2016. We evaluated 2 Hb cohorts: "high" (above) and "low" (below) the mean discharge Hb level of 9.4 g/dL, comparing patient characteristics, blood utilization, and clinical outcomes including 30-day readmission rates. We further evaluated the effects of the lowest (<8 g/dL) discharge Hb levels on 30-day readmission rates by dividing the patients into 4 anemia cohorts based on discharge Hb levels: "no anemia" (>12 g/dL), "mild anemia" (10-11.9 g/dL), "moderate anemia" (8-9.9 g/dL), and "severe anemia" (<8 g/dL). Risk adjustment accounted for age, sex, Charlson comorbidity index, preoperative comorbidities, revision sternotomy, and patient blood management program implementation. RESULTS: The "high" and "low" groups had similar patient characteristics except for Hb levels (mean discharge Hb was 10.4 ± 0.9 vs 8.5 ± 0.6 g/dL, respectively). Notably, no evidence for a difference in 30-day readmission rates was noted between the "high" (76/746; 10.2%) and "low" (97/806; 12.0%) (P = .25) Hb cohorts. The 4 anemia cohorts had differences in age, revision sternotomy incidence, Hb levels, certain patient comorbidities, and time to readmission. On multivariable analysis, the risk-adjusted odds of readmission in the "low" Hb cohort (odds ratio, 1.16; 95% confidence interval, 0.84-1.61; P = .36) was not significant compared to the "high" Hb cohort. Compared to patients with discharge Hb ≥8 g/dL, patients with Hb <8 g/dL had a higher incidence of readmission (22/129; 17.1% vs 151/1423; 10.6%; P = .036). On multivariable analysis, Hb <8 g/dL on discharge was predictive of readmission (odds ratio, 1.77; 95% confidence interval, 1.05-2.88; P = .03). The most common reason for readmission was volume overload, followed by infection and arrhythmias. CONCLUSIONS: A discharge Hb level below the institution mean for CABG patients does not provide evidence for an association with an increased 30-day readmission rate. In the small number of patients discharged with Hb <8 g/dL, there is a suggestion of increased risk for readmission and larger more controlled studies are needed to verify or refute this finding.
BACKGROUND: Restrictive transfusion strategies supported by large randomized trials are resulting in decreased blood utilization in cardiac surgery. What remains to be determined, however, is the impact of lower discharge hemoglobin (Hb) levels on readmission rates. We assessed patients with higher versus lower Hb levels on discharge to compare 30-day readmission rates after coronary artery bypass grafting (CABG). METHODS: We retrospectively evaluated 1552 patients undergoing isolated CABG at our institution from January 2013 to May 2016. We evaluated 2 Hb cohorts: "high" (above) and "low" (below) the mean discharge Hb level of 9.4 g/dL, comparing patient characteristics, blood utilization, and clinical outcomes including 30-day readmission rates. We further evaluated the effects of the lowest (<8 g/dL) discharge Hb levels on 30-day readmission rates by dividing the patients into 4 anemia cohorts based on discharge Hb levels: "no anemia" (>12 g/dL), "mild anemia" (10-11.9 g/dL), "moderate anemia" (8-9.9 g/dL), and "severe anemia" (<8 g/dL). Risk adjustment accounted for age, sex, Charlson comorbidity index, preoperative comorbidities, revision sternotomy, and patient blood management program implementation. RESULTS: The "high" and "low" groups had similar patient characteristics except for Hb levels (mean discharge Hb was 10.4 ± 0.9 vs 8.5 ± 0.6 g/dL, respectively). Notably, no evidence for a difference in 30-day readmission rates was noted between the "high" (76/746; 10.2%) and "low" (97/806; 12.0%) (P = .25) Hb cohorts. The 4 anemia cohorts had differences in age, revision sternotomy incidence, Hb levels, certain patient comorbidities, and time to readmission. On multivariable analysis, the risk-adjusted odds of readmission in the "low" Hb cohort (odds ratio, 1.16; 95% confidence interval, 0.84-1.61; P = .36) was not significant compared to the "high" Hb cohort. Compared to patients with discharge Hb ≥8 g/dL, patients with Hb <8 g/dL had a higher incidence of readmission (22/129; 17.1% vs 151/1423; 10.6%; P = .036). On multivariable analysis, Hb <8 g/dL on discharge was predictive of readmission (odds ratio, 1.77; 95% confidence interval, 1.05-2.88; P = .03). The most common reason for readmission was volume overload, followed by infection and arrhythmias. CONCLUSIONS: A discharge Hb level below the institution mean for CABG patients does not provide evidence for an association with an increased 30-day readmission rate. In the small number of patients discharged with Hb <8 g/dL, there is a suggestion of increased risk for readmission and larger more controlled studies are needed to verify or refute this finding.
Authors: Lawrence T Goodnough; Paul Maggio; Eric Hadhazy; Lisa Shieh; Tina Hernandez-Boussard; Paul Khari; Neil Shah Journal: Transfusion Date: 2014-07-04 Impact factor: 3.157
Authors: Steven M Frank; Linda M S Resar; James A Rothschild; Elizabeth A Dackiw; Will J Savage; Paul M Ness Journal: Transfusion Date: 2013-04-29 Impact factor: 3.157
Authors: Lars B Holst; Nicolai Haase; Jørn Wetterslev; Jan Wernerman; Anne B Guttormsen; Sari Karlsson; Pär I Johansson; Anders Aneman; Marianne L Vang; Robert Winding; Lars Nebrich; Helle L Nibro; Bodil S Rasmussen; Johnny R M Lauridsen; Jane S Nielsen; Anders Oldner; Ville Pettilä; Maria B Cronhjort; Lasse H Andersen; Ulf G Pedersen; Nanna Reiter; Jørgen Wiis; Jonathan O White; Lene Russell; Klaus J Thornberg; Peter B Hjortrup; Rasmus G Müller; Morten H Møller; Morten Steensen; Inga Tjäder; Kristina Kilsand; Suzanne Odeberg-Wernerman; Brit Sjøbø; Helle Bundgaard; Maria A Thyø; David Lodahl; Rikke Mærkedahl; Carsten Albeck; Dorte Illum; Mary Kruse; Per Winkel; Anders Perner Journal: N Engl J Med Date: 2014-10-01 Impact factor: 91.245
Authors: C David Mazer; Richard P Whitlock; Dean A Fergusson; Judith Hall; Emilie Belley-Cote; Katherine Connolly; Boris Khanykin; Alexander J Gregory; Étienne de Médicis; Shay McGuinness; Alistair Royse; François M Carrier; Paul J Young; Juan C Villar; Hilary P Grocott; Manfred D Seeberger; Stephen Fremes; François Lellouche; Summer Syed; Kelly Byrne; Sean M Bagshaw; Nian C Hwang; Chirag Mehta; Thomas W Painter; Colin Royse; Subodh Verma; Gregory M T Hare; Ashley Cohen; Kevin E Thorpe; Peter Jüni; Nadine Shehata Journal: N Engl J Med Date: 2017-11-12 Impact factor: 91.245
Authors: Colleen G Koch; Daniel I Sessler; Edward J Mascha; Joseph F Sabik; Liang Li; Andra I Duncan; Nicole M Zimmerman; Eugene H Blackstone Journal: Ann Thorac Surg Date: 2017-08-16 Impact factor: 4.330
Authors: Colleen Gorman Koch; Liang Li; Andra I Duncan; Tomislav Mihaljevic; Delos M Cosgrove; Floyd D Loop; Norman J Starr; Eugene H Blackstone Journal: Crit Care Med Date: 2006-06 Impact factor: 7.598
Authors: Ludhmila A Hajjar; Jean-Louis Vincent; Filomena R B G Galas; Rosana E Nakamura; Carolina M P Silva; Marilia H Santos; Julia Fukushima; Roberto Kalil Filho; Denise B Sierra; Neuza H Lopes; Thais Mauad; Aretusa C Roquim; Marcia R Sundin; Wanderson C Leão; Juliano P Almeida; Pablo M Pomerantzeff; Luis O Dallan; Fabio B Jatene; Noedir A G Stolf; Jose O C Auler Journal: JAMA Date: 2010-10-13 Impact factor: 56.272
Authors: Jeffrey M Rohde; Derek E Dimcheff; Neil Blumberg; Sanjay Saint; Kenneth M Langa; Latoya Kuhn; Andrew Hickner; Mary A M Rogers Journal: JAMA Date: 2014-04-02 Impact factor: 56.272
Authors: Mehdi H Shishehbor; Surabhi Madhwal; Vivek Rajagopal; Amy Hsu; Peter Kelly; Hitinder S Gurm; Samir R Kapadia; Michael S Lauer; Eric J Topol Journal: JACC Cardiovasc Interv Date: 2009-01 Impact factor: 11.195
Authors: Mitchell J Kerfeld; Daryl J Kor; Ryan D Frank; Andrew C Hanson; Melissa A Passe; Matthew A Warner Journal: Transfusion Date: 2020-08-13 Impact factor: 3.157
Authors: Vugar Nabi; Selim Ayhan; Selcen Yuksel; Prashant Adhikari; Alba Vila-Casademunt; Ferran Pellise; Francisco Sanchez Perez-Grueso; Ahmet Alanay; Ibrahim Obeid; Frank Kleinstueck; Emre Acaroglu Journal: Asian Spine J Date: 2021-06-17